Tools
Stock profile

MSA Safety Inc (MSA)

MSA · Latest close $177.45 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$177.45
As of Nov 18, 2026
Tracked funds holding
3 of 149
2026 Q2 13F filings
Opened / added
1 / 0
vs previous quarter
Trimmed / exited
2
vs previous quarter

MSA Safety Inc (MSA) is held by 3 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 1 fund opening new positions and 2 funds trimming or exiting versus the previous quarter. Latest close $177.45 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: none in the last 90 days · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Fundamentals
Revenue · FY2025
Red flags
none flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Government relations · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

Ruane Cunniff LP · Giverny Capital · Mairs & Power Funds — 3 tracked funds hold MSA. See all holders.

Insider and Congress activity

No insider open-market activity or Congress trades reported for this stock in the recent window. Insider trading · Politician trading.

Often held alongside

BERKSHIRE HATHAWAY INC (BRK.A) · SCHWAB CHARLES CORP (SCHW) · AMERICAN EXPRESS CO (AXP) · INTUITIVE SURGICAL INC (ISRG) · ZIMMER BIOMET HOLDINGS, INC. (ZBH) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Ruane Cunniff LP4.68%1,721,415TRIMMED (-3.1%) Q3 filed Nov 16
Giverny Capital0.98%166,305NEW Q3 filed Nov 12
Mairs & Power Funds<0.01%1,470HELD Q3 filed Nov 16
First Eagle Investment Management——EXITED

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: +1.5% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

203.08127.302024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

All institutions · Form 13F

Institutions holding456 of 8,857 filers
Long-only filers among them455
Change vs 2026 Q1+18 net · 434 entered · 416 exited
Shares reported, all filers35,199,914
Reported value, all filers$5.9B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNYSE
IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Revenue · FY2025$1.9B
Net income · FY2025$278.9M
Total assets · FY2025$2.6B
Shares outstanding38,578,289
Market cap (at latest close)$6.8B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Jul 24, 2026.

Short interest

Shares short · Oct 15, 20261,140,638
Share of shares outstanding2.96%
Days to cover5.03

Shares short at recent settlements — Jul 31, 2026: 1.3M · Aug 14, 2026: 1.0M · Aug 31, 2026: 809K · Sep 15, 2026: 878K · Sep 30, 2026: 1.0M · Oct 15, 2026: 1.1M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Jul 24, 2026.

Fails to deliver

Shares failed to deliver · Oct 14, 20268
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 2026<0.1%

Fails to deliver at recent settlements — Jul 31, 2026: 1K · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 8.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Jul 24, 2026.

Insider trading · Form 4

Data unavailable — no Form 4 transactions for this ticker were parsed in the last 90 days.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
Aug 18, 2026Howells David JFormer Officer3,407$645.6KAug 18, 2026SEC filing
Aug 7, 2026NISHAN J VARTANIANDirector20,000$3.9MAug 7, 2026SEC filing
Sep 12, 2025Sciullo Stephanie LOfficer2,361$406.8KSep 12, 2025SEC filing
Sep 11, 2025Brody Elyse LOfficer1,034$178.2KSep 11, 2025SEC filing
Sep 11, 2025Sciullo Stephanie LOfficer5,000$861.9KSep 11, 2025SEC filing
Aug 22, 2025Roberts Rebecca BFormer Director250$43.8KAug 22, 2025SEC filing
Jul 16, 2025Roberts Rebecca BFormer Director439$75.1KJul 16, 2025SEC filing
Jun 10, 2025Roberts Rebecca BFormer Director500$83.4KJun 10, 2025SEC filing
May 13, 2025NISHAN J VARTANIANDirector30,000$4.8MMay 13, 2025SEC filing
Jul 31, 2024NISHAN J VARTANIAN & PAMELA A VARTANIANNon-Executive Director3,945$745.6KJul 31, 2024SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Apr 30, 2026Vanguard Capital ManagementSC 13G1,985,5905.1%Mar 31, 2026SEC filing
Mar 27, 2026The Vanguard GroupSC 13G/A00.0%Mar 13, 2026SEC filing
Jul 31, 2025JPMORGAN CHASE & CO.SC 13G/A1,808,2964.6%Jun 30, 2025SEC filing
Feb 10, 2025JPMORGAN CHASE & CO.SC 13G1,994,1035.0%Dec 31, 2024SEC filing
Jan 7, 2025APG Asset Management US Inc.SC 13G1,883,6124.8%Dec 31, 2024SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).

Committee jurisdiction

Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842). Standing committees with jurisdiction over this industry: Senate Committee on Health, Education, Labor, and Pensions, House Committee on Energy and Commerce.

None of the members who traded this stock in the current window sit on these committees.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Government relations

Lobbying: 24 Lobbying Disclosure Act filings named this company as client, 2020–2025; most common issues: Health Issues (19), Government Issues (2), Disaster Planning/Emergencies (1).

Federal contracts: $64.5M in obligated amounts, fiscal years 2021–2026.

Fiscal yearObligated amount
FY2021$8.4M
FY2022$8.0M
FY2023$46.3M
FY2024$1.8M
FY2025$0
FY2026$0

Largest awards collected

Award IDAgencyAmountStart
FA853324F0061Department of Defense$28.6MJul 18, 2024
70Z04024F62306B00Department of Homeland Security$15.3MSep 25, 2024
FA853423F0045Department of Defense$14.7MMar 24, 2023
70Z04024F62138B00Department of Homeland Security$7.1MAug 22, 2024
15JPSS24F00000949Department of Justice$4.4MSep 30, 2024

Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.

Screens & lenses

Financial Screens

· Growth — Revenue up every year for 5 straight years

· Graham — Sound finances and a long run of profits

· Dividend Growth — Dividends raised for more than 10 years

· Earnings Quality (Cash Conversion) — Profits that actually come back as cash

Chart Signals

· Monthly Uptrend — Price above its 12-month moving average

Key figures

· Growth — Latest revenue: $1.9B · 5-yr revenue CAGR: 6.8% · Straight growth years: 5

· Graham — Current ratio: 3.01 · Straight profitable years: 18 · Debt ratio: 0.87 · Latest net income: $278.9M

· Dividend Growth — Dividend per share: 2.10 · Dividend yield: 1.2% · Straight dividend years: 7 · 10-yr dividend growth: —

· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 1.31 · Operating cash flow: $363.9M · Net income: $278.9M

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Also held by the tracked funds that hold MSA — ranked by lift, the co-holding pattern described in Methodology: BERKSHIRE HATHAWAY INC (BRK.A) · SCHWAB CHARLES CORP (SCHW) · AMERICAN EXPRESS CO (AXP) · INTUITIVE SURGICAL INC (ISRG) · ZIMMER BIOMET HOLDINGS, INC. (ZBH) · Edwards Lifesciences Corp (EW) · ESTABLISHMENT LABS HOLDINGS INC. (ESTA) · STERIS plc (STE).

5 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.

Recent 8-K filings

FiledItemsSource
Nov 2, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing
Jul 30, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing
Jul 21, 20265.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain OfficersSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

BERKSHIRE HATHAWAY INC (BRK.A) · Track Record: how the signals scored · Practice timing on MSA

One email a week: the week’s new filings and research. Subscribe free

← MS  ·  MSCI →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.